Back to News
Market Impact: 0.15
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents
Source: Business Wire
Healthcare & BiotechProduct LaunchesRegulation & Legislation
The company completed enrollment in a study intended to support an anticipated indication expansion for its Swoop system when used with contrast agents. The milestone advances the potential regulatory and commercial expansion of the medical-imaging product, though no clinical results, timing, or financial impact were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- China's AI leaders keep quiet despite U.S. 'publicity' on tech risks
- US Senate crypto bill collapses in blow to industry
- BlackRock’s Fink, Blackstone’s Gray Back Carney’s Canada Investment Push
- Factbox-How AI leaders and world governments react to ’AI doom’ fears
- Two camps have emerged in the debate over AI safety and regulation
- Push for AI regulation mounts as talk of AI’s ‘existential’ risks go mainstream. But Trump resists calls for a slowdown